{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:36:23Z","timestamp":1790793383114,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4079,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Spontaneous recovery occurs in a minority of patients with acute hepatitis C but is associated with vigorous and long-lasting cellular immune responses. Treatment-induced recovery can be achieved in the majority of patients who are treated in the acute phase, but the kinetics and mechanisms of viral clearance and immune responsiveness are not known. Both direct antiviral effects and indirect immune-mediated effects, such as immune modulation of Th2 to Th1 responses and prevention of exhaustion of cellular responses by rapid reduction of viral titer, have been proposed. To investigate how early antiviral therapy affects hepatitis C virus (HCV)-specific T cell responses, we performed detailed prospective clinical, virological, and immunological studies on 7 patients with acute hepatitis C who received antiviral therapy and were followed at 2 to 4 week intervals for 1 to 2 years. The total CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> cell response was analyzed with 600 overlapping HCV peptides and 6 proteins by <jats:italic toggle=\"yes\">ex vivo<\/jats:italic> enzyme-linked immunospot (ELISpot), intracellular cytokine staining, and proliferation assays. In contrast to earlier studies with selected HCV epitopes, this extended analysis detected multispecific interferon \u03b3<jats:sup>+<\/jats:sup> (IFN-\u03b3<jats:sup>+)<\/jats:sup> responses in each patient, even in the absence of T-cell proliferation. After initiation of antiviral therapy (at a mean of 20 weeks after infection), all sustained responders demonstrated gradually decreasing, then nearly absent HCV-specific T-cell responses, whereas the sole patient who developed viral breakthrough after initial HCV control maintained cellular immune responses. <jats:underline>In conclusion<\/jats:underline>, a sustained response to antiviral therapy was not associated with a lasting enhancement of HCV-specific T-cell responsiveness in the blood. (Hepatology 2004;40:87-97.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.20253","type":"journal-article","created":{"date-parts":[[2004,7,2]],"date-time":"2004-07-02T07:03:11Z","timestamp":1088751791000},"page":"87-97","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":102,"title":["Effects of antiviral therapy on the cellular immune response in acute hepatitis C"],"prefix":"10.1097","volume":"40","author":[{"given":"Fareed","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Sobao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eishiro","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelina","family":"Nascimbeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Herrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake T.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rehermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-16-20241201","first-page":"S21S29","article-title":"Course and outcome of hepatitis C.","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R2-16-20241201","doi-asserted-by":"crossref","first-page":"331338","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States.","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"R3-16-20241201","first-page":"S195S200","article-title":"Therapy of acute hepatitis C.","volume":"36","author":"Alberti","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R4-16-20241201","first-page":"14521457","article-title":"Treatment of acute hepatitis C with interferon alfa-2b.","volume":"20","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-16-20241201","first-page":"8088","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"R6-16-20241201","doi-asserted-by":"crossref","first-page":"296305","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C.","volume":"132","author":"Liang","year":"2000","journal-title":"Ann Intern Med"},{"key":"R7-16-20241201","doi-asserted-by":"crossref","first-page":"975982","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"R8-16-20241201","doi-asserted-by":"crossref","first-page":"958965","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"R9-16-20241201","doi-asserted-by":"crossref","first-page":"10061007","DOI":"10.1016\/S0140-6736(95)91691-1","article-title":"Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.","volume":"346","author":"Diepolder","year":"1995","journal-title":"Lancet"},{"key":"R10-16-20241201","doi-asserted-by":"crossref","first-page":"14991512","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus.","volume":"191","author":"Lechner","year":"2000","journal-title":"J Exp Med"},{"key":"R11-16-20241201","doi-asserted-by":"crossref","first-page":"13951406","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection.","volume":"194","author":"Thimme","year":"2001","journal-title":"J Exp Med"},{"key":"R12-16-20241201","doi-asserted-by":"crossref","first-page":"580587","DOI":"10.1016\/0016-5085(93)90430-K","article-title":"T-lymphocyte response to hepatitis C virus in different clinical courses of infection.","volume":"104","author":"Botarelli","year":"1993","journal-title":"Gastroenterology"},{"key":"R13-16-20241201","doi-asserted-by":"crossref","first-page":"706714","DOI":"10.1172\/JCI118842","article-title":"Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.","volume":"98","author":"Missale","year":"1996","journal-title":"J Clin Invest"},{"key":"R14-16-20241201","first-page":"15281536","article-title":"Association of hepatitis C virus-specific CD8 T cells with viral clearance in acute hepatitis C.","volume":"181","author":"Gruener","year":"2000","journal-title":"J Infect Dis"},{"key":"R15-16-20241201","doi-asserted-by":"crossref","first-page":"578582","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist, humoral responses decrease two decades after recovery from a single source outbreak of hepatitis C.","volume":"6","author":"Takaki","year":"2000","journal-title":"Nat Med"},{"key":"R16-16-20241201","doi-asserted-by":"crossref","first-page":"23762385","DOI":"10.1172\/JCI119778","article-title":"Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.","volume":"100","author":"Chang","year":"1997","journal-title":"J Clin Invest"},{"key":"R17-16-20241201","doi-asserted-by":"crossref","first-page":"11451148","DOI":"10.1126\/science.1082604","article-title":"Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease.","volume":"300","author":"Foy","year":"2003","journal-title":"Science"},{"key":"R18-16-20241201","doi-asserted-by":"crossref","first-page":"107110","DOI":"10.1126\/science.285.5424.107","article-title":"Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.","volume":"285","author":"Taylor","year":"1999","journal-title":"Science"},{"key":"R19-16-20241201","doi-asserted-by":"crossref","first-page":"217227","DOI":"10.1006\/viro.1997.8493","article-title":"Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.","volume":"230","author":"Gale","year":"1997","journal-title":"Virology"},{"key":"R20-16-20241201","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1084\/jem.20011124","article-title":"Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.","volume":"195","author":"Crotta","year":"2002","journal-title":"J Exp Med"},{"key":"R21-16-20241201","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1084\/jem.20011145","article-title":"Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.","volume":"195","author":"Tseng","year":"2002","journal-title":"J Exp Med"},{"key":"R22-16-20241201","doi-asserted-by":"crossref","first-page":"12391249","DOI":"10.1172\/JCI10323","article-title":"Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.","volume":"106","author":"Kittlesen","year":"2000","journal-title":"J Clin Invest"},{"key":"R23-16-20241201","doi-asserted-by":"crossref","first-page":"34473458","DOI":"10.4049\/jimmunol.169.6.3447","article-title":"Impaired effector function of hepatitis C virus-specific CD8 T cells in chronic hepatitis C virus infection.","volume":"169","author":"Wedemeyer","year":"2002","journal-title":"J Immunol"},{"key":"R24-16-20241201","doi-asserted-by":"crossref","first-page":"253256","DOI":"10.1016\/S0016-5085(03)00807-2","article-title":"New insights into acute hepatitis C.","volume":"125","author":"Gordon","year":"2003","journal-title":"Gastroenterology"},{"key":"R25-16-20241201","doi-asserted-by":"crossref","first-page":"104113","DOI":"10.1016\/S1590-8658(03)00007-0","article-title":"Natural course of acute hepatitis C: a long-term prospective study.","volume":"35","author":"Santantonio","year":"2003","journal-title":"Dig Liver Dis"},{"key":"R26-16-20241201","first-page":"6064","article-title":"Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load.","volume":"37","author":"Hofer","year":"2003","journal-title":"HEPATOLOGY"},{"issue":"Suppl 1","key":"R27-16-20241201","first-page":"S35SS36","article-title":"Natural history of chronic hepatitis C.","volume":"36","author":"Seeff","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R28-16-20241201","doi-asserted-by":"crossref","first-page":"1018710199","DOI":"10.1128\/JVI.75.21.10187-10199.2001","article-title":"Role of CD8() lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment.","volume":"75","author":"Lifson","year":"2001","journal-title":"J Virol"},{"key":"R29-16-20241201","doi-asserted-by":"crossref","first-page":"173178","DOI":"10.1126\/science.271.5246.173","article-title":"Immunology taught by viruses.","volume":"271","author":"Zinkernagel","year":"1996","journal-title":"Science"},{"key":"R30-16-20241201","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0166-3542(03)00088-3","article-title":"Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C.","volume":"59","author":"Pawlotsky","year":"2003","journal-title":"Antiviral Res"},{"key":"R31-16-20241201","doi-asserted-by":"crossref","first-page":"439449","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus.","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"key":"R32-16-20241201","doi-asserted-by":"crossref","first-page":"16451655","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8 T cells are required for protection from persistent hepatitis C virus infection.","volume":"197","author":"Shoukry","year":"2003","journal-title":"J Exp Med"},{"key":"R33-16-20241201","doi-asserted-by":"crossref","first-page":"1566115668","DOI":"10.1073\/pnas.202608299","article-title":"Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.","volume":"99","author":"Thimme","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-16-20241201","doi-asserted-by":"crossref","first-page":"251262","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development.","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R35-16-20241201","doi-asserted-by":"crossref","first-page":"24792487","DOI":"10.1002\/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B","article-title":"CD8 T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained.","volume":"30","author":"Lechner","year":"2000","journal-title":"Eur J Immunol"},{"issue":"Suppl 1","key":"R36-16-20241201","doi-asserted-by":"crossref","first-page":"354A","DOI":"10.1016\/S0270-9139(03)80446-9","article-title":"T cell responses during early therapy for HCV infection. Abstract.","volume":"38","author":"Lauer","year":"2003","journal-title":"HEPATOLOGY"},{"issue":"Suppl 1","key":"R37-16-20241201","doi-asserted-by":"crossref","first-page":"358A","DOI":"10.1016\/S0270-9139(03)80454-8","article-title":"Acute hepatitis C infection following patellar tendon transplantation: immunologic correlates of recovery. Abstract.","volume":"38","author":"Tester","year":"2003","journal-title":"HEPATOLOGY"},{"issue":"Suppl 1","key":"R38-16-20241201","doi-asserted-by":"crossref","first-page":"357A","DOI":"10.1016\/S0270-9139(03)80452-4","article-title":"Differential mechanism of interferon-induced and spontaneous clearance of hepatitis C virus infection. Abstract.","volume":"38","author":"Kaplan","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R39-16-20241201","doi-asserted-by":"crossref","first-page":"267276","DOI":"10.1053\/jhep.2001.21162","article-title":"Differential CD4 and CD8 T-cell responsiveness in hepatitis C virus infection.","volume":"33","author":"Chang","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R40-16-20241201","doi-asserted-by":"crossref","first-page":"577589","DOI":"10.1053\/jhep.2003.50115","article-title":"Novel CD4 and CD8 T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.","volume":"37","author":"Wertheimer","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R41-16-20241201","doi-asserted-by":"crossref","first-page":"61046113","DOI":"10.1128\/JVI.76.12.6104-6113.2002","article-title":"Comprehensive analysis of CD8()-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.","volume":"76","author":"Lauer","year":"2002","journal-title":"J Virol"},{"key":"R42-16-20241201","doi-asserted-by":"crossref","first-page":"14791487","DOI":"10.1053\/jhep.2001.24371","article-title":"Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.","volume":"33","author":"Bassett","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R43-16-20241201","doi-asserted-by":"crossref","first-page":"47814793","DOI":"10.1128\/JVI.77.8.4781-4793.2003","article-title":"Kinetics of CD4 and CD8 memory T cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.","volume":"77","author":"Nascimbeni","year":"2003","journal-title":"J Virol"},{"key":"R44-16-20241201","first-page":"301305","article-title":"A comparative trial of recombinant interferon alpha 2A versus alpha 2 beta on myelosuppression in healthy adult volunteers.","volume":"43","author":"Wong","year":"1996","journal-title":"Hepatogastroenterology"},{"key":"R45-16-20241201","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1111\/j.1600-065X.1999.tb01327.x","article-title":"Stimulation of naive and memory T cells by cytokines.","volume":"170","author":"Tough","year":"1999","journal-title":"Immunol Rev"},{"key":"R46-16-20241201","doi-asserted-by":"crossref","first-page":"11271135","DOI":"10.1084\/jem.179.4.1127","article-title":"Turnover of naive- and memory-phenotype T cells.","volume":"179","author":"Tough","year":"1994","journal-title":"J Exp Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.20253","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200407000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:00:33Z","timestamp":1733054433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200407000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.20253","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}